这是一篇来自已证抗体库的有关
人类 PPAR的综述，是根据26篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合PPAR 抗体。
PPAR 同义词: NR1C1; PPAR; PPARalpha; hPPAR
圣克鲁斯生物技术
| 小鼠 单克隆 | | 圣克鲁斯生物技术 PPAR抗体（Santa Cruz, Sc-398394)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 6h). NPJ Breast Cancer (2021) ncbi |
| 小鼠 单克隆 | | 圣克鲁斯生物技术 PPAR抗体（Santa Cruz, sc-398394)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 s6b). Mol Metab (2021) ncbi |
| 小鼠 单克隆 | - 免疫组化基因敲除验证; 小鼠; 1:1000; 图 2a, 2b
- 免疫印迹基因敲除验证; 小鼠; 1:1000; 图 2j
| 圣克鲁斯生物技术 PPAR抗体（Santa Cruz, sc-398394)被用于被用于免疫组化基因敲除验证在小鼠样本上浓度为1:1000 (图 2a, 2b) 和 被用于免疫印迹基因敲除验证在小鼠样本上浓度为1:1000 (图 2j). Nutrients (2021) ncbi |
| 小鼠 单克隆 | | 圣克鲁斯生物技术 PPAR抗体（Santa Cruz, sc-398394)被用于被用于免疫印迹在小鼠样本上 (图 6b). Oxid Med Cell Longev (2021) ncbi |
| 小鼠 单克隆 | | 圣克鲁斯生物技术 PPAR抗体（Santa Cruz Biotechnology, sc-398394)被用于被用于免疫印迹在小鼠样本上 (图 5a). Cell Rep (2019) ncbi |
| 小鼠 单克隆 | | 圣克鲁斯生物技术 PPAR抗体（Santa Cruz, sc398394)被用于被用于免疫印迹在人类样本上 (图 3f). Br J Pharmacol (2018) ncbi |
| 小鼠 单克隆 | | 圣克鲁斯生物技术 PPAR抗体（Santa Cruz Biotechnology Inc, sc-398394)被用于被用于免疫组化-冰冻切片在小鼠样本上 (图 4c). J Biol Chem (2018) ncbi |
| 小鼠 单克隆 | | 圣克鲁斯生物技术 PPAR抗体（Santa Cruz, sc-398394)被用于被用于免疫印迹在人类样本上 (图 12c). Mol Cell Endocrinol (2018) ncbi |
| 小鼠 单克隆（467D1a） | | 圣克鲁斯生物技术 PPAR抗体（Santa Cruz, sc-130640)被用于被用于免疫印迹在大鼠样本上浓度为1:200 (图 4). Mol Med Rep (2015) ncbi |
| 小鼠 单克隆（467D1a） | | 圣克鲁斯生物技术 PPAR抗体（santa cruz, sc-130640)被用于被用于免疫印迹在人类样本上 (图 6b). Int J Mol Med (2015) ncbi |
赛默飞世尔
| domestic rabbit 多克隆 | | 赛默飞世尔 PPAR抗体（ThermoFisher Scientific, PA1-822A)被用于被用于免疫印迹在人类样本上 (图 3s3b). elife (2020) ncbi |
| 小鼠 单克隆（3B6/PPAR） | | 赛默飞世尔 PPAR抗体（Thermo Fisher Scientific, MA1-822)被用于被用于免疫印迹在小鼠样本上 (图 2c). Food Funct (2017) ncbi |
| domestic rabbit 多克隆 | | 赛默飞世尔 PPAR抗体（Pierce, PA1-822A)被用于被用于免疫印迹在小鼠样本上 (图 6i). Biochim Biophys Acta Mol Cell Biol Lipids (2017) ncbi |
| domestic rabbit 多克隆 | - 免疫组化-石蜡切片; 人类; 1:250; 图 1
- 免疫印迹; 人类; 1:400; 图 4
| 赛默飞世尔 PPAR抗体（Thermo Scientific, PA1-822A)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:250 (图 1) 和 被用于免疫印迹在人类样本上浓度为1:400 (图 4). Mol Cell Endocrinol (2016) ncbi |
| domestic rabbit 多克隆 | - 免疫印迹; 人类; 1:1000; 图 1
- 免疫组化; 小鼠; 1:200; 图 2
| 赛默飞世尔 PPAR抗体（Pierce, PA1-822A)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 1) 和 被用于免疫组化在小鼠样本上浓度为1:200 (图 2). Nat Med (2016) ncbi |
| domestic rabbit 多克隆 | | 赛默飞世尔 PPAR抗体（Pierce, PA1-822A)被用于. Arch Biochem Biophys (2015) ncbi |
| domestic rabbit 多克隆 | | 赛默飞世尔 PPAR抗体（ThermoFisher Scientific, PA1-822A)被用于. Am J Physiol Gastrointest Liver Physiol (2015) ncbi |
艾博抗（上海）贸易有限公司
| domestic rabbit 多克隆 | | 艾博抗（上海）贸易有限公司 PPAR抗体（Abcam, ab3484)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5f). Biomed Res Int (2021) ncbi |
| domestic rabbit 多克隆 | | 艾博抗（上海）贸易有限公司 PPAR抗体（Abcam, ab24509)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 5d). iScience (2021) ncbi |
| domestic rabbit 多克隆 | | 艾博抗（上海）贸易有限公司 PPAR抗体（Abcam, ab215270)被用于被用于免疫印迹在小鼠样本上 (图 4a). Nat Commun (2021) ncbi |
| domestic rabbit 多克隆 | | 艾博抗（上海）贸易有限公司 PPAR抗体（Abcam, ab215270)被用于被用于免疫印迹在斑马鱼样本上浓度为1:1000 (图 3c). Cancers (Basel) (2021) ncbi |
| domestic rabbit 多克隆 | | 艾博抗（上海）贸易有限公司 PPAR抗体（Abcam, ab24509)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 6a). Front Pharmacol (2020) ncbi |
| domestic rabbit 多克隆 | | 艾博抗（上海）贸易有限公司 PPAR抗体（Abcam, Ab3484)被用于被用于免疫印迹在大鼠样本上 (图 3a). FEBS Open Bio (2017) ncbi |
| domestic rabbit 多克隆 | | 艾博抗（上海）贸易有限公司 PPAR抗体（Abcam, Ab24509)被用于被用于免疫印迹在小鼠样本上 (图 1b). Gut (2016) ncbi |
亚诺法生技股份有限公司
| domestic rabbit 多克隆 | | 亚诺法生技股份有限公司 PPAR抗体（Abnova, PAB11321)被用于被用于免疫印迹在小鼠样本上浓度为1:1000 (图 st3). Sci Rep (2017) ncbi |
Cayman Chemical
| domestic rabbit 多克隆 | | 开曼群岛化学品 PPAR抗体（开曼群岛化学品, 101710)被用于被用于免疫印迹基因敲除验证在小鼠样本上 (图 5). elife (2016) ncbi |
Gyamfi J, Yeo J, Kwon D, Min B, Cha Y, Koo J,
et al. Interaction between CD36 and FABP4 modulates adipocyte-induced fatty acid import and metabolism in breast cancer. NPJ Breast Cancer. 2021;7:129
pubmed 出版商 Lin Y, Wu X, Zheng C, Zhang Q, Zhang G, Chen K,
et al. Mechanistic Investigation on the Regulation of FABP1 by the IL-6/miR-603 Signaling in the Pathogenesis of Hepatocellular Carcinoma. Biomed Res Int. 2021;2021:8579658
pubmed 出版商 Li Y, Chen L, Li L, Sottas C, Petrillo S, Lazaris A,
et al. Cholesterol-binding translocator protein TSPO regulates steatosis and bile acid synthesis in nonalcoholic fatty liver disease. iScience. 2021;24:102457
pubmed 出版商 Srivastava S, Zhou H, Setia O, Liu B, Kanasaki K, Koya D,
et al. Loss of endothelial glucocorticoid receptor accelerates diabetic nephropathy. Nat Commun. 2021;12:2368
pubmed 出版商 Malvi P, Janostiak R, Nagarajan A, Zhang X, Wajapeyee N. N-acylsphingosine amidohydrolase 1 promotes melanoma growth and metastasis by suppressing peroxisome biogenesis-induced ROS production. Mol Metab. 2021;48:101217
pubmed 出版商 Antonuccio P, Marini H, Micali A, Romeo C, Granese R, Retto A,
et al. The Nutraceutical N-Palmitoylethanolamide (PEA) Reveals Widespread Molecular Effects Unmasking New Therapeutic Targets in Murine Varicocele. Nutrients. 2021;13:
pubmed 出版商 Lai C, Yeh K, Lin C, Hsieh Y, Lai H, Chen J,
et al. MicroRNA-21 Plays Multiple Oncometabolic Roles in the Process of NAFLD-Related Hepatocellular Carcinoma via PI3K/AKT, TGF-β, and STAT3 Signaling. Cancers (Basel). 2021;13:
pubmed 出版商 Tao S, Yang Y, Li J, Wang H, Ma Y. Bixin Attenuates High-Fat Diet-Caused Liver Steatosis and Inflammatory Injury through Nrf2/PPARα Signals. Oxid Med Cell Longev. 2021;2021:6610124
pubmed 出版商 Hu J, Zhu Z, Ying H, Yao J, Ma H, Li L,
et al. Oleoylethanolamide Protects Against Acute Liver Injury by Regulating Nrf-2/HO-1 and NLRP3 Pathways in Mice. Front Pharmacol. 2020;11:605065
pubmed 出版商 Contat C, Ancey P, Zangger N, Sabatino S, Pascual J, Escrig S,
et al. Combined deletion of Glut1 and Glut3 impairs lung adenocarcinoma growth. elife. 2020;9:
pubmed 出版商 Naiman S, Huynh F, Gil R, Glick Y, Shahar Y, Touitou N,
et al. SIRT6 Promotes Hepatic Beta-Oxidation via Activation of PPARα. Cell Rep. 2019;29:4127-4143.e8
pubmed 出版商 Zhang C, Deng J, Liu D, Tuo X, Xiao L, Lai B,
et al. Nuciferine ameliorates hepatic steatosis in high-fat diet/streptozocin-induced diabetic mice through a PPARα/PPARγ coactivator-1α pathway. Br J Pharmacol. 2018;175:4218-4228
pubmed 出版商 Huang L, Liu J, Zhang X, Sibley K, Najjar S, Lee M,
et al. Inhibition of protein arginine methyltransferase 5 enhances hepatic mitochondrial biogenesis. J Biol Chem. 2018;293:10884-10894
pubmed 出版商 Valanejad L, Ghareeb M, Shiffka S, Nadolny C, Chen Y, Guo L,
et al. Dysregulation of Δ4-3-oxosteroid 5β-reductase in diabetic patients: Implications and mechanisms. Mol Cell Endocrinol. 2018;470:127-141
pubmed 出版商 Lin Y, Tai S, Chen J, Chou C, Fu S, Chen Y. Ameliorative effects of pepsin-digested chicken liver hydrolysates on development of alcoholic fatty livers in mice. Food Funct. 2017;8:1763-1774
pubmed 出版商 Chen Z, Wang Q. Activation of PPAR? by baicalin attenuates pulmonary hypertension in an infant rat model by suppressing HMGB1/RAGE signaling. FEBS Open Bio. 2017;7:477-484
pubmed 出版商 Dadson K, Hauck L, Hao Z, Grothe D, Rao V, Mak T,
et al. The E3 ligase Mule protects the heart against oxidative stress and mitochondrial dysfunction through Myc-dependent inactivation of Pgc-1α and Pink1. Sci Rep. 2017;7:41490
pubmed 出版商 Milligan S, Martin G, Landrock D, McIntosh A, Mackie J, Schroeder F,
et al. Impact of dietary phytol on lipid metabolism in SCP2/SCPX/L-FABP null mice. Biochim Biophys Acta Mol Cell Biol Lipids. 2017;1862:291-304
pubmed 出版商 Rando G, Tan C, Khaled N, Montagner A, Leuenberger N, Bertrand Michel J,
et al. Glucocorticoid receptor-PPAR? axis in fetal mouse liver prepares neonates for milk lipid catabolism. elife. 2016;5:
pubmed 出版商 Rotondi S, Modarelli A, Oliva M, Rostomyan L, Sanità P, Ventura L,
et al. Expression of Peroxisome Proliferator-Activated Receptor alpha (PPARα) in somatotropinomas: Relationship with Aryl hydrocarbon receptor Interacting Protein (AIP) and in vitro effects of fenofibrate in GH3 cells. Mol Cell Endocrinol. 2016;426:61-72
pubmed 出版商 Dickey A, Pineda V, Tsunemi T, Liu P, Miranda H, Gilmore Hall S,
et al. PPAR-δ is repressed in Huntington's disease, is required for normal neuronal function and can be targeted therapeutically. Nat Med. 2016;22:37-45
pubmed 出版商 Li P, Luo S, Pan C, Cheng X. Modulation of fatty acid metabolism is involved in the alleviation of isoproterenol-induced rat heart failure by fenofibrate. Mol Med Rep. 2015;12:7899-906
pubmed 出版商 Loyer X, Paradis V, Hénique C, Vion A, Colnot N, Guerin C,
et al. Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARα expression. Gut. 2016;65:1882-1894
pubmed 出版商 Martin G, Atshaves B, Landrock K, Landrock D, Schroeder F, Kier A. Loss of L-FABP, SCP-2/SCP-x, or both induces hepatic lipid accumulation in female mice. Arch Biochem Biophys. 2015;580:41-9
pubmed 出版商 Klipsic D, Landrock D, Martin G, McIntosh A, Landrock K, Mackie J,
et al. Impact of SCP-2/SCP-x gene ablation and dietary cholesterol on hepatic lipid accumulation. Am J Physiol Gastrointest Liver Physiol. 2015;309:G387-99
pubmed 出版商 Kang O, Kim S, Mun S, Seo Y, Hwang H, Lee Y,
et al. Puerarin ameliorates hepatic steatosis by activating the PPARα and AMPK signaling pathways in hepatocytes. Int J Mol Med. 2015;35:803-9
pubmed 出版商
